Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.2 USD | -3.63% | -0.41% | +15.26% |
04:15pm | Oppenheimer Adjusts IDEAYA Biosciences Price Target to $53 From $50, Maintains Outperform Rating | MT |
07/05 | IDEAYA Biosciences Shares Fall After Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.26% | 3.2B | |
+22.56% | 46.4B | |
-1.59% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.09% | 26.01B | |
-18.95% | 19.52B | |
+29.05% | 12.43B | |
+0.14% | 12.18B | |
-0.39% | 12.13B |
- Stock Market
- Equities
- IDYA Stock
- News IDEAYA Biosciences, Inc.
- Ideaya Biosciences Insider Sold Shares Worth $4,495,550, According to a Recent SEC Filing